Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2023-10-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의청약결과(자율공시)(일반공모 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding the results of a public subscription for a capital increase (paid-in capital increase/rights offering) by the company U2Bio. It details the subscription results, including the number of shares subscribed by institutional and general investors, the subscription rate, and the upcoming payment and listing schedule. This falls under the category of share issuance and capital changes.
2023-10-24 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed by U2Bio. It is a formal regulatory filing submitted to the Financial Services Commission and the Korea Exchange. It details the correction of previously filed information (정정신고) concerning the offering price, use of proceeds, and subscription methods. This falls under the category of capital and financing updates as it pertains to the company's fundraising activities and capital structure changes.
2023-10-20 Korean
유상증자최종발행가액확정(일반공모)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the finalization of the issue price for a capital increase (paid-in capital increase/rights offering) by the company U2Bio. It specifies the number of shares, the final price per share, and the date of determination. This falls under the category of share issuance and capital changes.
2023-10-20 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the offering price (공모가액 확정) for U2Bio Co., Ltd. and provides updated information regarding the offering terms, allocation ratios, and subscription details. This is a formal regulatory filing related to a public offering of shares, which falls under the category of Regulatory Filings (RNS) as it is a specific type of securities registration amendment.
2023-10-20 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '정정신고서' (Amendment Filing) for an '투자설명서' (Prospectus) regarding a public offering (IPO) for U2Bio. It details changes to the offering price, total offering amount, and allocation ratios between institutional and retail investors. In the context of financial filings, a prospectus amendment related to an IPO or capital raising is classified under 'Capital/Financing Update' (CAP).
2023-10-20 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) for '주식회사 유투바이오' (U2Bio Co., Ltd.), dated October 11, 2023. It details the offering of 1,128,720 common shares, including offering price, subscription period, and payment dates. It also contains extensive sections on investment risks (business and company risks), which are standard components of a formal securities registration statement/prospectus. Since this is a formal regulatory document filed for a public offering of securities, it falls under the category of a prospectus/offering document, which is classified as a Regulatory Filing (RNS) in the absence of a specific 'Prospectus' category.
2023-10-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.